High Court dismisses pharmacists' claim that state remuneration cuts were a disproportionate interference with property rights.
Legislator-Zusammenfassung
KI-generiertThe High Court dismissed the plaintiffs' claim that recent reductions in state remuneration for community pharmacists constituted a disproportionate interference with their property rights. The plaintiffs argued the cuts were an unjust attack on their rights, while the defendants contended the reductions were necessary and proportionate given the emergency nature of the legislation. The court found the measures rationally connected to important social objectives and impaired rights as little as possible, thus refusing the requested injunction and damages.
Legislator-Regeste
KI-generiertHealth Act 1970, s. 59; Constitution of Ireland, Art. 40.1.1; The court held that legislative reductions in remuneration for community pharmacists do not constitute a disproportionate interference with property rights if the measures are rationally connected to pressing social objectives and impair rights as little as possible.
Schlagwörter
KI-generiertZitierte Gesetzesbestimmungen
KI-generiertZitierte Rechtsprechung
KI-generiertVerwandte Entscheide
KI-generiertVolltext
Neutral Citation Number: [2009] IEHC 562
THE HIGH COURT
2009 6546 P
BETWEEN
J. & J. HAIRE & COMPANY LIMITED, THOMASTOWN PHARMACY LIMITED, BORRIS PHARMACY LIMITED, GRAIGNAMANAGH
PHARMACY LIMITED AND HAIRE PHARMACY HOLDINGS LIMITED
PLAINTIFFS
AND
THE MINISTER FOR HEALTH AND CHILDREN, THE MINISTER FOR FINANCE, IRELAND AND THE ATTORNEY GENERAL
DEFENDANTS
JUDGMENT of Mr. Justice McMahon on the 17th day of December, 2009
1. Introduction and Background
Under the Health Act 1970, a new system for providing free general medical services and medicines to eligible persons was introduced.
Sections 59(1) and 59(3) of the Act imposed on the then Health Boards - now the Health Service Executive (“the HSE”) - mandatory
obligations to discharge the functions imposed by those subsections, namely to supply without charge medicines and other products
to certain eligible persons.
Prior to 1970, persons entitled to free medicines obtained the prescribed medicines through the public dispensaries. The new method
provided for distribution of medicines, etc., to eligible persons, through the existing network of independent pharmacists spread
throughout the country. Clearly, to do this, agreement would have to be reached with the pharmacists. Negotiations were
commenced between the Department of Health on behalf of the Minister and the Irish Pharmaceutical Union (“the IPU”), or more
properly the Pharmaceutical Contractors’ Committee (“the PCC”), on behalf of the pharmacists. A standard template agreement was
finalised in a memorandum dated October 1971 and this template was adopted by each pharmacy when it made its individual
agreement with the Health Board (now the HSE). The original agreement negotiated in 1971 was amended from time to time and was
the contract which the plaintiffs had with the HSE at the time relevant to these proceedings. Further details of this contract will be
addressed later in this judgement, but in essence the pharmacists were to distribute the medicines, etc., free of charge to the eligible
persons and were to recover from the State remuneration calculated on agreed rates set out in the contract.
The plaintiffs in this case are limited liability companies and are part of the Kissanes Group. The first found named plaintiffs are each a
party to a contract with the HSE, referred to as “the Community Pharmacy Contractors Agreement” (“the Contract”) which is a
standard form agreement negotiated between the IPU and the Minister for Health and Children. The Contract regulates conditions
under which the plaintiffs provide services for the State under various government schemes including the General Medical Scheme
(GMS), the Drugs Payment Scheme, the Long Term Illness Scheme, the European Economic Area Scheme and the Health
(Amendment) Act 1996 Scheme. Under the Contract the plaintiffs are contracted to distribute to entitled members of the public free
of charge medicines to which they are entitled under the various schemes. The Minister has set out in the Contract the charges
which the pharmacist will be entitled to recover from the State for this service. The terms of the Contract are primarily to be found in
the version signed between the parties in May 1996 as amended subsequently from time to time by various memoranda.
Due to “a serious disturbance in the economy and a decline in the economic circumstances of the State … which threaten the well-
being of the community”, the government, to address the economic crisis, introduced the Financial Emergency Measures in the Public
Interest Act 2009 (“the 2009 Act”). In addition to providing for a pension levy, the Act was passed to enable Ministers of the
Government:-
“To provide for the reduction of the amount payable, or rate of payment, out of money provided by the Oireachtas or the
central fund…to certain persons for certain services to or on behalf of the State…”
Section 9 of the Act makes provision for the reduction of payments to health professionals. Shortly after the Act was passed, several
Statutory Instruments were passed by various Ministers reducing the payments in respect of services rendered by various providers
to the State. These Statutory Instruments, according to the plaintiffs, purported to reduce the payments in respect of state
solicitors (see S.I. 159 of 2009), consultant psychiatrists (see S.I. 172 of 2009) and veterinary practitioners (see S.I. 216 of 2009) by
approximately 8%.
Statutory Instrument No. 246 of 2009 contained the Regulations directed at community pharmacy contractors whereby the Minister
for Health and Children introduced new rates and allowances payable to pharmacists operating within the relevant schemes under the
Contract.
The plaintiffs allege that the new fee structure imposed on them will result in at least a 24% reduction in their income under the
schemes and that such a reduction will make them insolvent.
2. The Plaintiffs’ Background
Each of the first four named plaintiffs in these proceedings is a limited liability company operating as a pharmacy and a subsidiary of
the fifth named plaintiff, a holding company. Mr. Haire and his wife are equal shareholders in the holding company. Mr. Haire is not a
plaintiff is these proceedings.
Mr. Haire was born in 1961 and completed his Leaving Certificate in 1979. He worked with his parents in the family pharmacy business
in Graignamanagh, Co. Kilkenny for two years before taking up employment with the General Medical Services (Payments) Board in
1981. He left this employment and enrolled for a Pharmacy Undergraduate Course in the University of Sunderland in 1990. He returned
to Ireland and to his employment with the Eastern Health Board, from which he had taken a career break, before taking over the
family pharmacy business in 1995 in Graignamanagh. The pharmacy had been in decline for several years due his parents’ advancing
years and failing health. On taking over the family business he set up J. & J. Haire and Company Limited (the first named plaintiff), his
first company, to run the family business. He expanded his business in 2001 by purchasing an owner managed pharmacy in
Thomastown, Kilkenny. In July 2002, after a legal battle, he opened up a pharmacy at Main Street, Borris, Co. Carlow. These
expansions put great financial strains on Mr. Haire and great demands in terms of energy and commitment. In 2005, a second
pharmacy in Graignamanagh came up for sale and because of its strategic location, near to the local GP, and to keep potential
competition out, the plaintiff purchased this pharmacy also.
3. The Legislation, the Regulations and the Contract
(a) The Financial Emergency Measures in the Public Interest Act 2009.
The purpose of the Act is set out in the long title to the Act and the reasons in justification for this piece of legislation are, most
unusually, set out in a series of recitals that precede the legislation itself. It is necessary to set out the recitals by way of
background to the legislation:-
“WHEREAS a serious disturbance in the economy and a decline in the economic circumstances of the State have
occurred, which threaten the well-being of the community;
AND WHEREAS as a consequence a serious deterioration in the revenues of the State has occurred and there are
significant and increasing Exchequer commitments in respect of public service pensions;
AND WHEREAS it is necessary to cut current Exchequer spending substantially to demonstrate to the international
financial markets that public expenditure is being significantly controlled so as to ensure continued access to international
funding, and to protect the State’s credit rating and reverse the erosion of the State’s international competitiveness;
AND WHEREAS the burden of job losses and salary reductions in the private sector has been very substantial and it is
equitable that the public sector should share that burden;
AND WHEREAS it is necessary to take the measures in this Act as part of a range of measures to address the economic
crisis;
AND WHEREAS the value of public service pensions is significantly and markedly more favourable than those generally
available in other employment.”
The relevant section which permits the Minister to reduce payments to health professionals is contained in s. 9 of the Act as follows:
“(1) Notwithstanding any other enactment, contract, arrangement, understanding, expectation, circular or instrument or
other document, the Minister for Health and Children may, with the consent of the Minister for Finance, by regulation,
reduce, whether by formula or otherwise, the amount or the rate of payment to be made to health professionals, or
classes of health professionals, in respect of any services that they render to or on behalf of a health body from the date
of the regulation.
(2) Subsection (1) shall apply to the services rendered from the date of the regulation, notwithstanding that the health
professionals concerned may have commenced the provision of the service prior to the date of the regulation.
(3) A regulation made under subsection (1) may fix different amounts or rates for different services, and as and from the
date of the regulation, there shall be no entitlement to payment in excess of the amounts and rates so specified,
although nothing in this section shall prevent any health professional from providing a service for a lesser amount or at a
lower rate.
(4) Prior to making a regulation under subsection (1), the Minister for Health and Children, or, at that Minister’s direction,
the health body concerned, shall engage in such consultations as that Minister considers appropriate.
(5) A regulation made under subsection (1) shall fix amounts or rates that the Minister for Health and Children considers
to be fair and reasonable in the light of the purposes of this Act, having regard to the matters which that Minister
considers appropriate, including any or all of the following:
(a) the terms of any existing contractual arrangements or understandings with the health professionals concerned
or any expectation on their part;
(b) the terms of any circular, instrument, or document which apply to the health professionals concerned;
(c) any submissions made and views expressed during the consultations under subsection (4);
(d) the nature of the services rendered by different classes of health professionals and the general nature of
expenses and commitments of the health professionals providing those services;
(e) the impact on the State’s ability to continue to provide health services at existing levels if reductions are not
made; and
(f) the fairness and efficiency of any method of effecting any reductions in payments having regard to the
requirements of good and effective administration.
(6) The powers conferred on or exercised by the Minister for Health and Children under this section shall not affect any
existing right to negotiate or amend rates or contracts generally which that Minister or the health body concerned enjoys
apart from this section, and those rights may be exercised in conjunction with, in addition to or instead of the powers
conferred by this Act.
(7) Consultations under subsection (4) shall be completed no later than 30 days after the Minister for Health and Children
gives notice of the commencement of the consultations.
(8) A health professional who does not wish to continue to render services to or on behalf of the health body concerned
on the basis of a payment regime fixed in a regulation made under subsection (1) may give 30 days’ notice to that effect
to the health body and, on the expiration of those 30 days, shall be relieved of any obligation to render those services
notwithstanding any contractual or other term with regard to notice.
(9) If a health body receives notice from a health professional under subsection (8), it may, notwithstanding any other
enactment, contract, implementing circular, instrument or other document, engage the services of other health
professionals to ensure that the services continue to be available.
(10) The Minister for Health and Children may define the manner in which consultations under subsection (4) are to be
conducted and conduct them in such manner, and with such representatives of health professionals or otherwise, as he
or she considers appropriate, and nothing in the Competition Act 2002 shall prevent participation by that Minister or any
such representative in such consultations, or the communication and discussion of the outcome of such consultations by
the representatives with the health professionals they represent.
(11) The Minister for Health and Children may make regulations to do anything that appears necessary or expedient for
bringing this section into operation, or facilitating its operation, with a view to fulfilling the purposes for which this Act
was enacted.
(12) Regulations made under subsection (11) may contain such incidental, supplementary and consequential provisions as
appear to the Minister for Health and Children to be necessary or expedient for the purposes of the regulations.
(13) Without prejudice to section 13, the Minister for Health and Children may from time to time and shall, before 30 June
in 2010 and every year after 2010, carry out a review of the operation, effectiveness and impact of the amounts and
rates fixed by regulation under this section and consider the appropriateness of those amounts and rates, having regard
to any change of circumstances and in particular any alteration of any of the matters mentioned in subsection (5).
(14) If, after completing a review under subsection (13), the Minister for Health and Children considers it appropriate to
do so, that Minister may, with the consent of the Minister for Finance, by regulation adjust (whether by formula or
otherwise) the amount or the rate of payment to be made to health professionals, or classes of health professionals, in
respect of any services that they render to or on behalf of a health body from the date of the regulation.
(15) Subsections (2) to (12) apply, with the necessary modifications, to the making of regulations under subsection (14).
(16) Regulations made under this section shall be laid before each House of the Oireachtas as soon as may be after they
are made and, if a resolution annulling the regulations is passed by either such House within the next 21 days on which
that House has sat after the regulations are laid before it, the regulations shall be annulled accordingly, but without
prejudice to the validity of anything previously done under the regulations.
(17) In this section –
‘health body’ means the Health Service Executive and any other body under the aegis of the Minister for Health and
Children wholly or partly funded by the Exchequer to which, or on behalf of which, health professionals render services;
and
‘health professional’ includes –
(a) a registered medical practitioner,
(b) a registered dentist,
(c) a registered pharmacist,
(d) an optometrist,
(e) an ophthalmologist,
(f) a podiatrist, and
(g) a chiropodist.
(18) Where the provider of a service of a kind normally provided by a health professional is a company or other body
corporate, or the legal personal representative of a deceased health professional, a reference in this section to a health
professional includes the company or other body corporate or legal personal representative.
(19) In this section, payment in respect of a service rendered by a health professional includes payment in respect of
goods provided by that health professional as part of the service.”
Section 10 of the Act enables the relevant Minister to make reductions with the consent of the Minister for Finance to other
professionals such as lawyers, architects etc. in respect of services they provide to the State.
Section 13 provides that the Minister for Finance shall carry out an annual review of this legislation and report his/her findings to both
houses of the Oireachtas. Section 14 enables the Minister for Finance to make regulations for the purposes of the Act or to give the
Act full effect.
(b) The Regulations
In exercise of the powers conferred under ss. 9 and 10 of the 2009 Act, various Regulations have been made reducing payments in
respect of services provided to the State by various service providers, including State solicitors, dentists, consultants psychiatrists,
ophthalmologists, optometrists and dispensing opticians, veterinary practitioners and general practitioners. The Regulations provide for
a reduction of approximately 8% in all of these cases.
The Regulations that particularly affect the plaintiffs in this case are the Health Professionals (Reduction of Payments to Community
Pharmacy Contractors) Regulations 2009 (S.I. No. 246 of 2009) (“the Regulations”). The relevant provisions of these Regulations are
as follows:
“2. In these Regulations –
‘community pharmacy contractor’ means a registered pharmacist, company or other body corporate that provides services
to the Health Service Executive under an agreement made in accordance with conditions specified by the Minister for
Health and Children in 1971 or 1996 for the provision of community pharmacy services to eligible persons under section 59
of the Health Act 1970, as amended from time to time;
‘controlled drug’ has the same meaning as in section 2 of the Misuse of Drugs Act 1977 (No. 12 of 1977);
‘ex-factory price’ with respect to a particular drug item at a particular time, means the price of that drug item determined
in accordance with the relevant agreements in force at that time between the Health Service Executive and
representative bodies of manufacturers and importers of such items;
‘fridge item’ means a drug item which must be kept in refrigerated storage conditions of between 2 and 8 degrees Celsius
as stated in the summary of product characteristics for that item;
‘ingredient cost’ means –
(a) in the case of controlled drugs and fridge items, the ex-factory price together with a wholesale mark-up of
17.66 per cent; and
(b) in the case of any other drug item, the ex-factory price together with a wholesale mark-up as specified in
Tables 2 and 3 below.
3. These Regulations shall apply to payments in respect of services rendered
by a community pharmacy contractor to or on behalf of the Health Service Executive in respect of the dispensing of drug
and non-drug items by a registered pharmacist under the General Medical Services Scheme, the Drug Payment Scheme,
the Long-Term Illness Scheme, the European Economic Area Scheme and the Health (Amendment) Act 1996 Scheme.
4. The payments (other than reimbursement of ingredient costs and retail mark-up for non-drug items and reimbursement
of ingredient costs for controlled drugs and fridge items) that shall be made to a community pharmacy contractor in
respect of the services referred to in Regulation 3 from the date of the making of these Regulations shall be those
specified in Tables 1, 2 and 3 below.”
I will postpone further reference to the payments until I have described the various schemes which are covered by the Regulations
and the method of payment and the rates applicable to each scheme that was in existence prior to the introduction of S.I. No. 246 of
2009.
(c) The Contract
Against the above background, it is now necessary to examine the Contract entered into between the plaintiffs and the HSE, the
terms of which are relevant in this case. Under the Contract, the pharmacy contractor undertakes to supply any GMS eligible person
or any other eligible person, who presents a properly completed prescription, such medicines as may be ordered. In discharging his
duties, the pharmacy contractor undertakes to exercise his/her professional judgment and to exercise due diligence and care towards
the patients. The pharmacy contractor also undertakes a number of other obligations including a commitment to certain hours of
opening as specified in the Contract.
Clauses 12 and 13 of the Contract which are of particular relevance read as follows:-
“12(1) The Board shall in consideration of the service provided by the pharmacy contractor in accordance with these
terms and conditions and on foot of claims made in the form and at the times directed by the Minister, make payments or
arrange for payments to be made to the pharmacy contractor for prescriptions dispensed at his/her contracted
community pharmacy in accordance with such rates as may be approved or directed by the Minister from time to time
after consultation with the Pharmaceutical Contractors Committee.” (Emphasis added).
Clause 13 provides:-
“13(1) The pharmacy contractor shall not demand or accept any payment or consideration whatsoever other than
payments under clause 12(1) in reward for the supply of medicines which under the Health Act, 1970 are to be supplied
without charge.”
Clause 19 is also relevant and provides:
“19(1) This Agreement will terminate forthwith on the pharmacy contractor or, in the case of a body corporate, the
supervising pharmacist, ceasing to be entitled to practice as a pharmacist or upon his/her ceasing to keep open shop for
the compounding and dispensing of medical prescription or on the cessation of the said contractors’ entitlement so to do.
(2) The pharmacy contractor may terminate the Agreement on giving three months notice in writing or such shorter period
of notice, in writing, as may be agreed by the Chief Executive Officer [of the defendant Board].
(3) This Agreement is to be construed as contingent upon the terms agreed or to be agreed between the Minister and the
Pharmaceutical Contractor’s Committee regarding arrangements for the provision of pharmaceutical services under the
provisions of the Health Act 1970. The pharmacy contractor and the Board agree that any changes in the terms of such
agreements, which may be agreed between the Minister and the Pharmaceutical Contractor’s Committee, shall be
incorporated into this Agreement and the terms of this Agreement shall be construed accordingly, following the issue of a
notification of such agreed changes by the Minister.
(4) Nothing in this Agreement shall interfere with the statutory functions prescribed from time to time of the Minister or
the Chief Execute Officer.
(5) The terms and conditions of this Agreement between the Pharmaceutical Contractor’s Committee and the Minister may
be subject to review after a period of five years. In default of agreement on any such review, the matters of this
Agreement shall be subject to mediation and recommendation by a third party appointed by the Minister following
consultation with the Pharmaceutical Contractor’s Committee. Any alterations to the Agreement between the Minister and
the Pharmaceutical Contractor’s Committee arising from the five year review provided for in this clause, shall be
incorporated into this Agreement and the terms of this Agreement shall be construed accordingly, following the issue of a
notification of such agreed changes by the Minister. The terms and conditions of this Agreement may also be extended for
special periods with the agreement of the Minister and the Pharmaceutical Contractor’s Committee.” (Emphasis added).
It is important to note that the payments to be made by the defendants are to be made “in accordance with such rates as may be
approved or directed by the Minister from time to time after consultation with the Pharmaceutical Contractors Committee”. (Clause
12(1)). The version of the Agreement that is applicable in the present circumstances is the 1996 standard form, as amended.
4. The Various Schemes, Pricing in the Pharmaceutical Sector and Remuneration of Pharmacists
The various schemes relevant to the current proceedings are:
(a) The General Medical Scheme (GMS)
(b) The Drugs Payment Scheme (DPS)
(c) The Long Term Illness Scheme (LTIS)
(d) The European Economic Area Scheme (EEAS) and
(e) The Health Amendment Act, 1996 Scheme (HAAS).
To appreciate the reimbursements paid by the State (under the old and new systems) under these schemes, it is necessary to outline
in brief how the distribution of pharmaceutical products operates in Ireland. At the apex of the distribution system are the
manufacturers and importers of the relevant medicines, etc. The distribution system is explained by Prof. Durkin, an Economist called
on behalf of the plaintiffs, and can be set out as follows:-
“Pharmaceutical wholesalers are the link between pharmaceutical manufacturing companies or importers/marketing
companies and retail pharmacies. Three wholesale companies, United Drugs, Unifar and Cahill May Roberts dominate the
wholesale market, taking about 90% of it, with United Drug accounting for about half of this, and Unifar about one third.
These wholesalers provide a wide range of drugs, estimated at about 12,000 to retail market, consisting of 14,000 retail
pharmacies, with twice daily deliveries. The wholesale sector is thus an important part of the supply chain, linking a large
number of suppliers and products with a large number of retail outlets.
Retail pharmacists deal directly with the public, their function is to dispense medicine to the public on the basis of doctors
prescriptions and to offer advice to the public both in terms of medicines prescribed, which may involve discussions with
GPs and the correct course of action in the case of minor and sometimes more serious ailments. They also carry non-
prescription medicines but can be competing with other retail outlets for the sale of these. Finally, many retail
pharmacists carry a range of other ‘front-of-house’ products from cosmetics to cameras. They also represent the frontline
of many State schemes for drugs like GMS, the Drug Payment Scheme, the Long Term Illness Scheme etc…
The majority of retail pharmacies are single-outlet pharmacies and do not form part of a chain or group. They are owned
and operated by a single pharmacist. In the past decade there has been some development of group on multi-chain
pharmacies and some foreign ownership. Boots are the most obvious example of a new foreign entrant to the market,
locating in the new shopping centres and acquiring some existing retail outlets. The Unicare Group was acquired by GEHE
part of the German CELESIO Group. There are also some domestic chains, such as McCabe’s, Hickeys, McCawleys.
However, the majority of pharmacies and a bulk of sales are through single outlet pharmacies. For a very short period
1996 to 2002 there were restrictions on the location of new pharmacies, but these are now gone. Since the restrictions
on location were removed there was an increase in the number of pharmacies but there has also been some pharmacy
failure.”
Unlike other businesses, the Government plays an important role in this process. The price which manufacturers/importers sell
products to the wholesalers (the ex-factory price) is fixed by agreement between the Irish Pharmaceutical and Healthcare Association
(IPHA), the association representing the manufacturers, and the Department of Health and Children. Wholesalers in turn, invoice retail
pharmacists at the ex-factory price plus a mark-up of 17.66%, giving a profit margin of 15% on sales price. If, for example, a product
is sold to a pharmacist for 100, the wholesaler receives a profit of 15. Taking this as a given, the State then has to determine what
reimbursement the retailers are entitled to when they dispense prescription medicines under the various schemes on behalf of the
State. The answer to this is that the State looks at the different schemes it has in place, and determines what it will pay the
pharmacist for operating the schemes on its behalf.
Discounts and Rebates
Before referring specifically to the prices fixed by the State, it is necessary to say a word about discounts and rebates which the
retailers were, over the years, able to get from the wholesalers for their business. Because of intense competition at the wholesale
level, the wholesalers, to retain the loyalty of the retailers, gave discounts or rebates in certain events to retailers which, in effect,
meant that the wholesaler was willing to share his 17.66% mark- up with the retailers. During the course of the hearing, the plaintiffs
indicated that the level of rebates that a particular retailer was able to command varied, sometimes being as low as 2% but on
average coming to between 8% and 10%. Mr. Haire gave evidence that, in his case, in the most recent times, he was able to
negotiate a rebate upwards from 10.25% to 10.75%. The plaintiffs also indicated that these rebates had to be earned by the retailer
and were not there simply for the asking. In particular, the plaintiff identified that rebates would be made available if:-
(i) there was an increase in the volume of orders placed by the retailer;
(ii) if the retailer undertook early payment; and
(iii) if an electronic order system was installed.
It is also significant to note that these rebates were negotiated by the retailer and it is important to note that the rebates were
calculated on the whole business between the wholesaler and the retailer and not just on that which was reimbursable by the State.
These rebates came into effect from the early 1990s and were in place well before the middle of 1999 when the existing Drugs
Payment Scheme was introduced. The level of rebates varied with each individual retailer and reflected the bargaining strength of the
retailer in the negotiations.
Once established, the rebating system meant that retailers could increase their profits greatly by getting from the wholesalers a
portion of the 17.66% which represented the wholesaler’s profit on the ex-factory price.
A central issue in this case, is the assertion by the State that in fixing a fair price for reimbursement to the retailers for administering
their schemes, the rebates should be taken into account by the State. The plaintiffs, on the other hand, argue that this is something
which the plaintiffs have “earned” and which arises from efforts on their own part and from their own business acumen and which has
nothing to do with the State. According to the plaintiffs, it should be disregarded, in calculating what is a fair price for their services
to the State under these schemes.
Crucial to the characterisation of the rebates is the economic analysis of the pharmaceutical market and the history of the
development of the wholesalers’ rebates.
Mr. Ridyard (the economist called by the State) argues that what happened from the mid-1990s was that wholesalers, being in a
better position to identify where savings could be made, introduced rebates (or discounts) at the end of each period when payment
was due, when the particular volume of medicines, etc., justified it. Other efficiencies from the pharmacists, such as earlier payment
schedules and electronic ordering, would also be factored in, in calculating the appropriate rebate. This development was apparently
driven by serious competition from other wholesalers. This competition was so intense that the number of wholesalers now operating
in the industry in Ireland has been reduced to three in the main. From this point of view, the State argues that the rebates are a
product of changes in the market rather than something that developed as a result of an initiative from the pharmacists/retailers, and
this justifies the State’s entitlement to recalibrate the payments.
Without engaging in an attempt to quantify anymore closely the respective contributions of each party to the rebate phenomenon, it
is sufficient to say that the emergence of the rebates can be attributed in a considerable part to each party and also to the way the
wholesale market has developed independently over the years. It would, however, be difficult to say, in this situation, that the
rebates are solely earned by the efforts of the pharmacist in general or, acknowledging that individual pharmacists negotiate the
appropriate level of rebate, by each pharmacy individually. Given its share in creating the conditions where rebates are possible, I am
of the view, in light of the emergence of the rebates as an economic factor, that the State was entitled to review the remuneration
paid to the pharmacists under the relevant schemes.
I accept in this connection the evidence of Mr. Ridyard that one could not do a proper economic assessment of what is happening in
the industry without taking into account all sources of remuneration to the pharmacists that arise “because the pharmacist has
carried out this activity of dispensing some medicine to a patient”.
It is also interesting to note that Mr. Ridyard, and Mr. Desmond, the witness from the Department of Health, were of the view that
the State was justified in revisiting the remuneration when the rebates was recognised as a serious factor before any economic crisis
arose.
I cannot for these reasons conclude that the Minister’s intervention in these circumstances was unreasonable or unwarranted. It is
not for this court to be any more intrusive in its examination of the Minister’s decision in that regard. Suffice to say it was neither
unreasonable nor unfair for her to take the rebates into account in reviewing the rates of remuneration due to pharmacists under the
Contract.
It is important to recall that Mr. Ridyard in his evidence emphasised that the question he was asked to consider was limited to the
following:-
“Assess whether in principle the reductions imposed on a pharmacist’s remuneration was reasonable.”
Mr. Ridyard’s evidence on what he considered to be reasonable, from an economist’s point of view, is to be found in the following
answer:-
“Essentially my conclusion was that the remuneration for pharmacies under the regulations represented a reasonable level
of remuneration for pharmacies and by ‘reasonable’ what I had in mind was a test whereby the regulations would give
sufficient remuneration to pharmacies, taking everything into account that would sustain a pharmacy network that was
able to do the job that it is there to do for the Irish consumer.”
In this, Mr. Ridyard was clear that he was not expressing any views as to what the court may ultimately, as a legal matter, conclude
was reasonable and, secondly, he was not in any position to advise the court on fairness insofar as an argument was being made of
disproportionate treatment or discrimination between the pharmacists and other health professionals.
Rates
Against this background, I now set out the rates of reimbursement under the various schemes which the State allowed to the
pharmacist up to recently and the new changes introduced as a consequence of the 2009 legislation.
GMS
Pre- Pharmacist reimbursed wholesale price (100) + 0% mark-
2009 up + €3.60 per item (dispensing fee)
Act
Post-2009 Act Pharmacist reimbursed wholesale price less 6.5% (93.5) + 0% mark-up
+ between €5.00, €4.50 and €3.50 (dispensing fee)
DPS, LTIS, EEAS and HAAS
Pre – 2009 ActPharmacist reimbursed wholesale (100) + 50% mark-up + €3.16 (dispensing fee)
Post-2009 Act Pharmacist reimbursed wholesale price less 6.5% (93.5) + 20% mark-
up + between €5.00, €4.50 and €3.50 (dispensing fee)
To contrast the old and the new rates of reimbursement, some comments are necessary.
The obvious reductions by the State is an attempt to factor into the new rates the fact that pharmacist retailers in recent years
have been getting significant discounts or rebates from the wholesalers which greatly boosted the retailers’ profits. This action by the
State can be justified, according to the defendants, by its view that the discounts granted by the wholesaler to the retail pharmacist
is to a great extent due to the volume of business given by the State to the pharmacist. The State affects the appropriate reduction
by notionally reducing the wholesale price by 6.5% i.e. from 100 to 93.5. The 6.5% reduction is the measure which the State
considers it is entitled to if the discount (rebate) is to be shared between the State and the retailers. Moreover, in the schemes
where a mark-up was allowed (DPS, LTIS, etc.), this was reduced from 50% to 20%. This resulted in a double reduction from the
pharmacist’s view, as not only was the margin reduced by 60%, but the base on which the 20% was now to be calculated also fell
from 100 to 93.5. To compensate somewhat for these cuts, the dispensing fee was by and large increased from a flat fee of €3.60 or
€3.16 to a sliding scale fee varying from €5.00 to €4.50 to €3.50, the higher fee being allowed for the first 20,000 units (in a year)
and the lowest for units in excess of 30,000 units.
The loss to the pharmacist retailers was most clearly seen in the DPS and other schemes where, under the old scheme, the retailer
would be reimbursed on a product costing him €100 a total of €153.16 (made up of 100 (the wholesale price) + €50 + €3.16), whereas
under the new scheme the retail pharmacist would only get a maximum of €117.20 and a minimum of €115.70.
There was some dispute initially between the parties as to what this represented by way of a loss in fee levels to the pharmacist. The
plaintiffs argued that it might be as high as 30%, whereas the defendant suggested that it was nearer 24%. At the hearing, however,
it was agreed between the parties that this did not need to be determined exactly by the court, as the plaintiffs indicated that it
could accept, for the purposes of its legal argument, the lower figure of 24%, since its case, based on unequal and disproportionate
treatment compared with the reductions to other health professionals, where the cuts were only in the order of 8%, would stand
whether the reduction to the pharmacists was 24% or 30%: the disparity in either case, according to the plaintiffs, spoke of
unfairness.
5. The Plaintiffs’ Case
The plaintiffs are directly challenging the constitutionality of both the 2009 Act and the Regulations made in respect of pharmacists
on the basis that they fail to vindicate the plaintiffs’ fundamental rights with regard to property and to equal treatment (which are
protected both under the Constitution and/or under the European Convention on Human Rights).
The plaintiffs plead their case under three broad headings:-
(a) The procedural arguments:
(i) the Regulations were not published or promulgated in a proper manner;
(ii) in making the Regulations, the Minister did not comply with the consultation procedure mandated by s. 9(4) of
the 2009 Act because she did not engage in a “meaningful” consultation with the pharmacists;
(b) The constitutional arguments:
(i) in making the Regulations the Minister exceeded what the 2009 Act permitted, because such swingeing
reductions to the pharmacists’ payments under the Contract were never intended by the Act (“principles and
policies” argument);
(ii) the reduction in the rates of remuneration for the pharmacists amounted to an interference with the plaintiffs’
property rights and are arbitrary and/or capricious and/or disproportionate and/or discriminatory when compared
with the cuts imposed on other health professionals; and
(iii) the reduction in the rates for pharmacists do not respect the principle of equal treatment when compared with
the lesser reduction in the rates for other professionals (including other health care professionals).
The property right which is infringed, according to the plaintiffs, is the contractual right the plaintiffs have with the HSE.
I will deal first with the plaintiffs’ procedural arguments and then consider the arguments based on interference with property rights
and, finally, the argument based on equal treatment.
Before doing so, however, I propose to deal with two recent judgments of the High Court which were opened in full and extensively
discussed at the hearing. The cases are Hickey v. Health Service Executive [2008] IEHC 290 and Irish Pharmaceutical Union v.
Minister for Health and Children [2007] IEHC 222.
6. Relevant Irish Case Law
In Irish Pharmaceutical Union v. Minister for Health and Children [2007] IEHC 222; (the “IPU case”) Clarke J. had to deal with a case
where the plaintiffs sought declarations against the defendants that the termination unilaterally by the Minister of a system of
“advanced payments”, which formed a term of the individual contract between the pharmacies and the HSE, amounted to a unilateral
variation of a contractual term and was not permissible. It is important to appreciate that this was a case framed in contract law. In
the course of his judgment, Clarke J. determined that the background “memorandum of agreement” between the IPU and the Minister,
which came into existence in 1971, and was subsequently superseded by a revised arrangement in 1996, did not constitute a legally
binding contract. The agreements between the individual pharmacies and the HSE were, however, legally binding contracts and
contained an inferred term concerning payments in advance. These relate to payments made by the HSE to the pharmacies to assist
with “cash flow” problems in the purchase of the relevant drugs. When the Minister decided to discontinue these “advanced
payments” she was in breach of the Contract, according to Clarke J. Although, the pharmacists’ contract was with the HSE (which
was not a party in the action), Clarke J. said that in view of the Minister’s involvement in the whole process, the plaintiffs were
entitled to a declaration against the Minister in the peculiar circumstances of that case.
It is important to note that in the IPU case the issue in dispute related to the provision of advance payments to the pharmacists.
Clarke J found that this provision was a term in the contract and that such a term could not be unilaterally revoked by the Minister.
At paragraph 7.4 of his judgment Clarke J said: “ …[it was] not open to one party to make a unilateral change in the terms unless the
contract itself allows for such an eventuality.” (Emphasis added). In that case no such saving provision could be found in the
Contract.
In the case before this Court, however, where the rates of remuneration in the Contract are at issue, clause 12(1) does allow the
Minister to change these rates unilaterally.
According to the defendants, the holding in the IPU case, supports the defendants in this case rather than the plaintiffs: the plaintiffs
do not have a contractual right to fixed rates into the future under the Contract and, accordingly, when the Minister chooses to
determine new rates of pay, she is not interfering with any of the plaintiffs’ contractual or property rights.
In Hickey v. Health Service Executive [2008] IEHC 290 (“Hickey”) Finlay Geoghegan J. also had to consider the nature and terms of
the Contract between the pharmacies and the HSE. In that case, the plaintiffs sued the defendant for breach of the Contract in
circumstances where the defendant reduced the amount paid as reimbursement for drugs supplied under the GMS and other
community drug schemes. Again, after a very detailed and helpful description of the background to the agreements between the HSE
and the pharmacies, Finlay Geoghegan J. held, having determined that the pharmacies were entitled under the Contract to a certain
rate of payment under the schemes, that the only way these rates could be varied was by decision of the Minister and not by a
decision of the HSE. For the HSE to attempt to do so unilaterally was, in effect, usurping a function of the Minister.
Hickey is important for other reasons. First, Finlay Geoghegan J. found that under clause 12(1) of the Contract the Minister was
entitled to determine the rates of pay unilaterally and she did not require the consent of anyone else to do so. In particular the
obligation to consult under the clause, did not in any way dilute her entitlement to make her own determination on the rates of pay.
Second, the phrase “rates of pay” as used in clause 12(1) is to be widely interpreted and includes not only professional fees, but also
extends to the wholesale mark-up and to the ingredient cost paid by retailers. This meant that the Minister is entitled unilaterally to
change downwards (i) the 17.66% mark-up formerly agreed as the appropriate increase to be allowed on the ex-factory price to get
the wholesale price, as well as (ii) the wholesale mark-up of 50% allowed to pharmacists under the non-GMS schemes. The
significance of these holdings will become apparent later in this judgement.
I repeat, however, perhaps for the reasons just stated, that the case before me is not a contract case, and the regulations
introduced by the Minister are challenged primarily on constitutional grounds.
7. The Plaintiffs’ Procedural Arguments.
(i) The Publication and the Entry into Force of the Regulations
The plaintiffs under this heading advanced the argument that the 2009 Regulations violate a fundamental principle that no legislative
measure can take effect before it is officially published. Although the argument featured in the written submissions of the plaintiffs, in
truth, it was not enthusiastically advanced at the hearing. It was not abandoned, however, and accordingly I am obliged to deal with
it.
The argument is set out in more detail at para. 22 of the plaintiffs’ written submissions as follows:-
“22. Section 9(16) of the Financial Emergency Measures in Public Interest Act 2009, requires that Regulations should be
placed before both Houses of the Oireachtas before they become law. Section 16(3) of the Interpretation Act 2005,
provides that, in the absence of any provision to the contrary, a statutory instruments takes effect on the day it was
signed, in this instance, July 1st, 2009 (there being no provision to the contrary). The 2009 Regulations were not laid
before the Houses of the Oireachtas until July 3rd, 2009, and were not officially published in Iris Oifigiúil until the 7th of
July, 2009. Although, the HSE wrote to notify pharmacists of the Regulations, six days after they were signed, on the 6th
day of July, 2009, but (sic) the Regulations which accompanied this letter were not signed and were stamped ‘proof
copy’.”
The plaintiffs themselves acknowledge that the point advanced is “ultra-technical” and that a court, even if it were to find that there
had been a breach of the alleged principle “may be tempted to say that the infringement of the principle of legality is de minimis and
should be overlooked”.
The plaintiffs cite no Irish authority to support this argument but rely, by way of analogy, on some authorities from the European
Court of Justice.
The plaintiffs’ argument, that a law or statutory instrument should not take effect until it has been formally published, has been
challenged by the defendants on several grounds. In addition to the facts set out by the plaintiffs, the defendants point out that on
the 18th June, 2009, the Minister published a press release in which she stated that the Regulations would come into force on the 1st
July, 2009, and set out the reductions which were to be made. Furthermore, the defendants point out that the Regulations are not
penal or retrospective in nature.
The defendants also point out, first, that the plaintiffs have no standing to make the present argument as no prejudice to the
plaintiffs has been identified to the court. A hypothetical argument is being advanced that a pharmacist wishing to terminate on
learning of the Regulations might have been prejudiced and also, that the thirty days notice a pharmacist must give to terminate
might have been given earlier if the Regulations were known at an earlier date. As indicated before this Court, however, it is clear
that the plaintiffs have not exercised and had no intention of exercising their right to terminate. It is well established that a challenge
of this nature cannot be entertained by the courts on a hypothetical basis, or on an ius tertii argument (see Madigan v. Attorney
General [1986] I.L.R.M. 136).
Second, contrary to the plaintiffs’ submissions, the defendants assert that there is no requirement that the Regulations should be laid
before the Houses of the Oireachtas or published in Iris Oifigiúil before they come into force. On the contrary, s. 9(16) of the 2009
Act provides that any Regulations made under this section should be laid before the Houses of the Oireachtas “as soon as may be
after they are made” (emphasis added).
Similar phraseology is used in s. 3 of the Statutory Instruments Act 1947 (as amended by s. 2 of the Statutory Instruments
(Amendment) Act 1955), which requires notice of a statutory instrument to be published in Iris Oifigiúil “as soon as may be after it is
made” (emphasis added). From the facts of this case it is clear that the Regulations complied with both requirements in this case.
Moreover, s. 3(2) of the 1947 Act expressly provides, in any event, that non-compliance with the requirements of s. 3(1) does not
effect “the validity or effect or coming into operation” of any statutory instrument, subject to s. 3(3) which is not relevant to this
case. The plaintiffs have not sought to impugn these provisions, even though these provisions were brought to their attention at the
interlocutory stage of these proceedings.
It is also noteworthy that the Constitution itself at Article 25.4.1 provides that when a Bill is signed by the President it comes into
operation on that day, unless a contrary intention appears. In that case there usually is a delay (small admittedly) before publication;
in any event publication is rarely instantaneous.
In view of these clear legislative and constitutional provisions it is difficult to see how the plaintiffs’ argument, based as it is on a
vague general principle, can be taken seriously when a full challenge is not made to the legislative provisions just referred to.
The case law cited by the plaintiffs from the European Court of Justice (Heinrich C-345/06 [2009] 3 C.M.L.R. 7; Skoma-Lux C-161/06
[2007] E.C.R. I-10841, para. 33, [2008] 1 C.M.L.R. 50; ROM–projecten C-158/06 [2007] E.C.R. I-5103, [2007] 3 C.M.L.R. 21) need
not be opened in detail. I am satisfied from reading these cases that in each case the facts can be distinguished from those before
this Court. More significantly, it would be dangerous to adopt out of context general quotations of principle from these cases which
emanate from a court operating in a very different legal system, and where there is an explicit provision in Article 254(2) of the EC
Treaty that a community regulation cannot take effect in law unless it is published in the Official Journal. The present Regulations
which concern this Court are not national measures taken to implement community legislation and, therefore, statements from the ECJ
are of limited, if any, effect in this jurisdiction.
For the above reasons I reject the plaintiffs’ arguments under this heading.
(ii) Failure to consult under s. 9(4) of the 2009 Act
The plaintiffs argue that the Minister failed to engage in a “meaningful” consultation under s. 9(4) of the Act prior to making the
decision to adopt the Regulations. In particular it is argued any consultation the Minister did engage in did not relate to the
“magnitude” of the reductions introduced under the Regulations. It is also suggested that the plaintiffs and “the pharmacy sector
generally were not on notice of the level and magnitude of the cuts” being contemplated. It is submitted that the nature of the
consultation process under s. 9(4) “must be subject to close and careful scrutiny by the Courts”.
Section 9(4) of the 2009 Act states:-
“(4) Prior to making a regulation under subsection (1), the Minister for Health and Children, or, at that Minister’s direction,
the health body concerned, shall engage in such consultations as that Minister considers appropriate.”
It is clear from this that the consultation mandated by the subsection is that which the “Minister considers appropriate”. This gives
the Minister a great measure of discretion in the matter.
The evidence is that the Minister (through the Department) did initiate a consultation process. On the 23rd December, 2008, the
Department wrote to the IPU and others inviting submissions. The IPU communicated with the Department and made a submission, but
sought an extension of the timeframe set by the Department as they complained that it did not have sufficient time to properly
engage with the process. The IPU, however, in making such requests were ignoring s. 9(7) of the Act which provides:-
“(7) Consultations under subsection (4) shall be completed no later than 30 days after the Minister for Health and Children
gives notice of the commencement of the consultations.”
That timeframe is fixed by statute and cannot be extended beyond the 30 days mentioned in section 9(7). This in itself indicates that
the Act contemplated that the consultation process allowed for in an Act dealing with financial emergency measures, was not to be
used to dilute the urgency that permeates the Act itself.
Furthermore, it must be noted that a great deal of consideration and deliberation had in fact already taken place between the
pharmacists (and the IPU) and the Department during the years 2007 and 2008 i.e. prior to the Hickey and IPU cases. After these
deliberations, the Department adopted measures which reflected the Department’s views on the necessary changes to the price
system and which were challenged in the Hickey case. These measures are substantially the same measures that are in the contested
Regulations, now at issue before this court.
Because the Hickey decision went in favour of the pharmacists on a technical point, the Department revisited the issue shortly after
that judgment once more and, having written to the IPU in December 2008 of its intention to engage in a consultation process under
clause 12(1) of the contract, it abandoned that process in favour of the consultation process provided for in s. 9(4) of the 2009 Act
when that Act came into force. Mr. Haire made a written submission on 19th March, 2009. Following its written submissions, the IPU
had a meeting with representatives of the Department and the HSE on 24th March, 2009. The evidence clearly shows that the IPU
could not have been, and was not, under any illusion as to what was at stake and that the Minister was contemplating substantial
reductions in the remuneration of pharmacists. Documentation also recorded that 104 named individuals/organisations submitted 110
submissions in total during the process, 75% of which appeared to be from individual pharmacists and small groups of pharmacies.
This factual background is important in considering the discretion of the Minister under s. 9(4) and in assessing what level of
consultation she considered “appropriate” in the circumstances of the case. The arguments for the price changes proposed had been
fully and extensively rehearsed and various aspects had been explored and canvassed with the parties during the years 2007 and
2008. The proposals contained in the Regulations were not plucked from the air. They had a long contentious history.
Although the plaintiffs, in their submissions, alleged “inadequate consultation”, no evidence, in fact, was offered to that effect and for
this reason alone, I am not prepared to accept that the consultation process was not “meaningful” and that the requirements of s.
9(4) were not met.
8. The Constitutionality Arguments
I have set out in, broad terms, the nature of the arguments advanced by the plaintiffs in support of their claim that the relevant
provisions of the 2009 Act and the Regulations are unconstitutional. These arguments can be summarised under the following
headings, and I propose to deal with them in this order:
(i) That the Regulations are outside the “principles and policies” of the 2009 Act;
(ii) That the Regulations interfere with the plaintiffs’ property rights, protected by the Constitution;
(iii) That the Minister, in making cuts to the rates of remuneration, did not treat the plaintiffs equally when compared with
the cuts made to the rates affecting other professionals, including other health care professionals
9. Principles and Policies Argument
The plaintiffs allege that the reductions in their rates of payment under the 2009 Act and the Regulations amount to unequal
treatment and/or are disproportionate when compared with the reductions made to the rates of payment for other professionals
(including other health care professionals and that this “extreme and disproportionate” disparate treatment does not come within the
“principles and policies” of the 2009 Act. If the Regulations do not come within the “principles and policies” of the 2009 Act, then they
are not authorised and are ultra vires the Minister having regard to Article 15.2 of the Constitution.
In Cityview Press Ltd. v. An Chomhairle Oiliúna [1980] I.R. 381 O’Higgins C.J., giving the judgment of the Supreme Court, said at p.
399 that where subordinate or delegated legislation is being challenged “the test is whether that which is challenged as an
unauthorised delegation of parliamentary power is more than a mere giving effect to the principles and policies which are contained in
the statute itself.” That well known case concerned a challenge to the provisions of the Industrial Training Act, 1967 allowing a
Minister to make Regulations under that Act. The Supreme Court rejected the challenge to the constitutionality of the legislation and
said at p. 399:
“The Act of 1967 contains clear declarations of policies and aims and it establishes machinery for the carrying out of
these policies and the achievement of these aims. In particular, the fact that there will be a levy is provided for in s. 21
and the obligation to pay it is laid down. The only matter which is left for determination by AnCO is the manner of
calculating this levy in relation to a particular industry. This is doing no more than adding the final detail which brings into
operation the general law which is laid down by the section. In addition, the Oireachtas has taken care to provide a
manner whereby a levy order made under that section will continue to be under the supervision of either House of the
Legislature itself. This is done under the provisions of sub-s. 6 of s. 21 whereby a levy order may be annulled by a
resolution of either House of the Oireachtas. In the opinion of the Court this is a permitted delegation of power to AnCO.
Accordingly, the claim that s. 21 of the Act of 1967 is unconstitutional fails.”
The facts of that case are strikingly similar, in many respects, to the facts of this case.
The plaintiffs draw attention to the recent attempts by the State to effect changes in the remuneration of the pharmacists, and
having failed in those attempts (see Hickey and IPU cases), the plaintiffs argue that the defendants are now attempting to introduce
the changes under the “cloak” of the 2009 Act.
I have already considered both the Hickey and IPU cases. In Hickey, the plaintiffs succeeded on the technical point that the HSE
attempted to introduce the reductions when under the Contract it should have been the Minister. Most of the other findings by Finlay
Geoghegan J., particularly relating to clause 12 of the Contract, went against the plaintiffs.
In IPU, Clarke J. held that there was an unilateral alteration of a term of the Contract by the Minister relating to “advance payments”.
He found in favour of the plaintiffs, but indicated that this was so because the Contract itself did not provide for a unilateral
alteration. It follows that had there been a provision in the Contract itself permitting such unilateral action, the plaintiffs would not
have succeeded. I conclude from this that had clause 12(1) been at issue, the plaintiffs would have failed.
The decisions in these cases do not suggest that in resorting to the 2009 Act here, the Minister was doing anything wrong, or was
trying to avoid resorting to the Contract itself to effect the changes she thought necessary. All parties agree that the Minister has
the power to reduce the rates under clause 12(1) of the Contract, so to suggest by introducing the Regulations, the Minister was
doing so under the “cloak” of the 2009 Act, is unconvincing.
The purpose of the 2009 Act is clear and can be discerned not only from the long title but also from the unusual recitals set out
earlier in this judgment. The purpose is to reduce State spending and, if necessary, to unilaterally reduce payments to service
providers. That, in fact, is the whole object of the exercise. The pharmacists argue that the cuts in their case are wholly
disproportionate and unequal. To succeed, proof of this “unequal treatment” would have to be produced, and I have no such proof.
Finally, it must be repeated that the pharmacists are liable to have cuts of this size imposed unilaterally, in any event, under their
contract with the State. I will refer again to this when considering the plaintiff’s property rights and the allegation based on the
arbitrariness and disproportionality of the Regulations.
It is difficult also to accept the argument made by the plaintiffs that the intervention made by the Minister into existing contractual
arrangements was something that “was never envisaged by the 2009 Act”. The whole purpose of s. 9 and, equally, of s. 10, was to
alter existing contracts, and reduce payments, where necessary.
I reject the plaintiffs’ argument insofar as it asserts that there is proof that the regulations in question do not give effect to the
principles and policies of the 2009 Act.
10. Alleged Interference with Property Rights
Section 9 of the Act, according to the plaintiffs, is such a far reaching provision, giving, as it does, the Minister power to unilaterally
alter existing contracts between health professionals and the HSE, that it must be considered to be contrary to the constitutional
provisions relating to property rights. As a general measure it is difficult, according to the plaintiffs, to see how this accords with the
essence of the property rights protected by Article 40.3.2 and Article 43 of the Constitution. Such a power cannot be regarded as “a
regulation” of property rights within the meaning of Article 43 and constitutes an “unjust attack” within the meaning of Article 40.3.2.
The power in s. 9 cannot be compared with accepted instances of regulation such as fixing minimum payment conditions, minimum
holidays, maximum working hours, etc., or regulating various activities by license or authorisation such as planning, taxi services,
activities with a public health dimension, etc. If such an interference is permissible under the Constitution then, the plaintiffs argue,
there are few limits as to the right of the Oireachtas to interfere with existing contractual commitments.
Property rights are protected in the Constitution under Article 40.3.2 and Article 43 of the Constitution. Article 43 provides-
“1.
(i) The State acknowledges that man, in virtue of his rational being, has the natural right, antecedent to positive
law, to the private ownership of external goods.
(ii) The State accordingly guarantees to pass no law attempting to abolish the right of private ownership or the
general right to transfer, bequeath, and inherit property.
2.
(i) The State recognises, however, that the exercise of the rights mentioned in the foregoing provisions of this
Article ought, in civil society, to be regulated by the principles of social justice.
(ii) The State, accordingly, may as occasion requires delimit by law the exercise of the said rights with a view to
reconciling their exercise with the exigencies of the common good.”
From this it is clear that Article 43 itself contemplates that the State may “regulate” the exercise of property rights having regard to
“the principles of social justice” and “the exigencies of the common good”.
Article 40.3.2 is perhaps more relevant to the specific case before the court. This declares:-
“The State shall, in particular, by its laws protect as best it may from unjust attack and, in the case of injustice done,
vindicate the life, person, good name, and property rights of every citizen.”
The relationship between Article 43 and Article 40.3.2 has been addressed by the Supreme Court in Blake v. Attorney General [1982]
I.R. 117 at p. 135 in the following terms:
“There exists, therefore, a double protection for the property rights of a citizen. As far as he is concerned, the State
cannot abolish our attempt to abolish the right of private ownership as an institution or the general right to transfer,
bequeath and inherit property. In addition, he has the further protection under Article 40 as to the exercise by him of his
own property rights in particular items of property.” [Emphasis added].
Keane C.J., delivering the judgment of the Supreme Court in Re. Article 26 and Part V of the Planning and Development Bill 1999
[2000] 2 I.R. 321, at p. 347 said:-
“…the interpretation of these Articles and, in particular, the analysis of the relationship between Article 40.3.2 and Article
43 have not been free from difficulty.”
There is a comprehensive discussion of the evolving jurisprudence on the matter in Hogan and Whyte, J.M Kelly: The Irish Constitution
(4th ed., pp. 1978 – 1993). From the survey of the case law, the learned authors conclude at p. 1993 that “when considering
constitutional protection of property rights, these Articles mutually inform each other”.
The plaintiffs advance their arguments based on alleged interference with property rights on a number of grounds:
(a) that the plaintiffs’ contractual entitlements, and in particular their right to receive the contractually agreed rates of
payment, are “property rights” within the meaning of the Constitution and that the plaintiffs enjoyed such property rights
in this case;
(b) that their property rights have been subject to “unjust attack” by the Minister in making the Regulations, purporting
to use her powers under the 2009 Act, in unilaterally making the reductions to the contractually agreed rates of payment
in this case;
(c) that the 2009 Act and the Regulations, in so far as they purport to enable the Minister to make swingeing cuts to the
plaintiffs’ contractually agreed rates of payment, amount to an “abrogation” (rather than a “regulation”) of the plaintiffs’
property rights;
(d) that the Minister acted in breach of the Contract, by not engaging clause 12(1) of the Contract, and instead chose to
rely on her powers under the 2009 Act in making the Regulations to reduce the rates of payment, and this breach of the
Contract also amounts to a “unjust attack” on the plaintiffs’ property rights.
It is clear that before a litigant can invoke the protection of Articles 43 and 40.3.2, he must be able to show that there is some
invasion or attack on an existing property right. If he has no property right in the first instance or the property rights which he has,
whether they are based on contract or not, are not as expansive as he maintains, then seeking protection from either Article 43 or
Article 40.3.2 is a futile exercise. Consideration of the unjustness of the attack, or the justification which the State may have in
passing the relevant measures (in this case the 2009 Act and the Regulations), that, for example, it is for the common good, simply
do not arise.
It has been held that property rights include contractual rights. In Condon v. Minister for Labour (No. 2) (unreported High Court, 11th
June, 1980) McWilliam J. said :
“As to section 3 of Article 40, accepting that the right to enter into contracts which are within the law and the right to
enforce such contracts are personal rights and that a right under a contract is a property right so as to be protected by
the provisions of the Article I would refer to the judgment of O’Higgins, C.J., in Moynihan v. Greensmyth (1977) I.R. 55 ….
O’Higgins, C.J., said at page 71, ‘proceeding therefore, on the assumption that the right to sue claimed by the plaintiff is a
property right which is guaranteed by Article 40, S.3, sub-S.2, of the Constitution, the question is whether that right has
been subjected to unjust attack or whether there has been an injustice which required vindication by the State. It is to
be noted that the guarantee of protection given by Article 40, S.3, sub-S. 2 of the Constitution is qualified by the words
‘as best it may’. This implies circumstances in which the State may have to balance its protection of the right against
other obligations arising from regard to the common good.’”
Insofar as a contractual right is a fundamental right in the Constitution, it has the protection of the common law rules of contract,
developed over the centuries and supplemented by legislation from time to time, and it is this code that is the State’s expression of
its protection of these contractual rights. The principles of contract law are well established and it must be assumed that they
provide adequate protection for the contractual rights of the parties where contracts are involved. It is only where such protection is
demonstrably inadequate that persons may come forward and make an independent argument based on Article 40.3.2 and Article 43
of the Constitution.
The defendants do not dispute that a contractual right is a property right and that such rights are protected by the Constitution. As
a general proposition, however, this is not very helpful. To appreciate the legal significance of this general comment and the strength
of the plaintiffs’ argument one must examine the nature of the contract and the relevant terms in more detail.
(a) What property rights do the plaintiffs have in this case?
In Shanley v. Commissioners for Public Works [1992] 2 I.R. 477 the plaintiff challenged the constitutionality of s. 4 of the Landlord
and Tenant (Amendment) Act, 1980 (as amended) on the grounds that it was repugnant to the provisions of Articles 40.3 and 43 of
the Constitution. The plaintiff was a tenant under a lease with the Minister for Finance. There was a clause in the relevant lease
allowing the tenancy to be terminated by notice. The plaintiff was served with a notice to quit. The plaintiff alleged the provisions of
the Landlord and Tenant Act 1931 applied to his lease giving him certain rights, including a right to renew the lease, which rights were
taken away by the provisions of s. 4 of the 1980 Act. The defendants argued that, on the contrary, the provisions of the 1931 Act
did not apply in the plaintiff’s case, and the plaintiff did not enjoy the rights he claimed were being interfered with by the provisions of
s. 4 of the 1980 Act. Carroll J. noted at p. 480 of her judgment that if the defendants were correct in their argument “the
constitutionality of s. 4, subs. 2 does not arise”. At p. 482 of her judgment Carroll J. found that the 1931 Act did not apply to State
property, contrary to the argument put forward by the plaintiff. She further said:
“But in this case since the plaintiff had no right as a State tenant to a renewal by virtue of s. 19 of the Landlord and
Tenant Act, 1931, no right was taken away by s. 4, sub. 2 of the 1980 Act. Therefore the question of constitutionality
does not arise”.
In that case there was no need for Carroll J. to consider whether there was any interference with the plaintiff’s property rights or
whether they were being subjected to “unjust attack” as the plaintiff had failed to establish that he enjoyed the property right (a
renewal of his lease) which he claimed he enjoyed. In my view, very similar considerations apply in this case.
In the Contract between the pharmacist and the HSE, the pharmacist agrees to supply goods and provide a service on behalf of the
HSE for certain rates of payment. The 2009 Regulations purport to reduce these rates from a certain date forward. It is important to
appreciate that the Regulations do not purport to introduce the changes retrospectively. Neither is there any attempt to confiscate
property in the sense of seizing goods or land. If such were attempted, of course, it could only be done under certain conditions and
could not normally be done without reasonable compensation.
The plaintiffs’ property rights in this instance are no more and no less than those rights which are accorded to him in the Contract.
Either the Minister is entitled to make the changes under the Contract or she is not. If she is entitled to do so, then she is not in
breach of the Contract; if she is not entitled to do so, she is first and foremost in breach of the Contract and the plaintiff’s primary
remedies are in contract. Bearing in mind the terms of the Contract in this case, and particularly clause 12(1) which allows the
Minister to change unilaterally the rate of remuneration, admittedly after consultation, there is little doubt that had the Minister
chosen to effect the rate changes by following the procedure provided for in clause 12(1) of the Contract, the plaintiffs could not
complain. There would have been no breach of the Contract and there would have been no infringement of a constitutional right
which, by definition, is no greater than the plaintiffs’ contractual right. A close look at the Contract between the pharmacists and the
HSE, does not disclose that the pharmacists have any right or entitlement for the rates of remuneration to continue indefinitely into
the future.
The so called right claimed by the pharmacists under the Contract is not in fact a right at all. At most it is merely a spes, a hope that
the present rates will continue. Whether they do, however, is not a matter which is to be determined by the pharmacists. It is a
matter exclusively for the Minister. From this analysis it can be seen that this is the height of the pharmacists’ entitlement under the
Contract.
The Minister did, in fact, commence the consultation process under clause 12(1), but when the 2009 Act was introduced she decided
to effect the rate change through the powers conferred by that legislation rather than under clause 12(1) of the Contract.
Presumably, she felt that this was a more effective way of achieving the changes she wished to bring about in the rates of payments.
The plaintiffs argue that the State cannot unilaterally change its contracts no more than any ordinary person. In support of this
position, the plaintiffs refer to the judgment of Clarke J. in the IPU case at para. 7.4 where he says:-
“Where there are, however, existing contractual relations it is not open to one party to make a unilateral change in those
terms unless the contract itself allows for such an eventuality. In the light of my finding that the advance payment
scheme formed part of the contractual relations between individual pharmacists and the HSE, then the Minister’s decision
to discontinue advanced payments amounts to a unilateral variation in the contractual terms. That is not permissible.”
(Emphasis added)
It must be noted, however, that what was at issue in that case was an attempt by the HSE to revoke a recognised term in the
Contract which made provision for “advanced payments” to the pharmacists. As I have already said, Clarke J. held that an attempt to
unilaterally revoke these payments was a breach of the Contract. But it is important to note that Clarke J. said, in the extract just
referred to, that the Minister could not take such unilateral action “unless the contract itself allows for such an eventuality”. In the
present case, however, while the Minister has unilaterally reduced the rates of payment in the Contract, such unilateral action is
provided for, and is allowed (after a consultation process) under the Contract itself at clause 12(1). A more explicit expression of
Clarke J’s view on this is to be found at para. 3.13 of his unreported judgment where he said:
“If the Minister has a binding contractual obligation, then he must comply with his contract irrespective of whether he
might have a legitimate basis for seeking to have it changed. On the other hand, if the Minister does not have a binding
contractual obligation, then the plaintiffs have no case in law.” [Emphasis added].
When confronted with this, the plaintiffs argue that clause 12(1) only permits the Minister to alter “the rates” and that it does not
permit the Minister to change “the whole structure of the agreement”. For example, counsel for the plaintiffs argues that it would not
be possible for the Minister under clause 12(1) to reduce the dispensing fee from €3.65 to €0.05 or to cut the ingredient cost by 30%
or 40%. That level of swingeing cuts is not what clause 12(1) contemplates or allows.
I do not interpret clause 12(1) in such a restrictive way. As I have already noted, clause 12(1) is not confined to alterations relating
to the fees allowed and the mark-ups. It is much broader and includes also, for instance, the ingredient cost as well. Finlay
Geoghegan J. in Hickey clearly determined this, and disagreed with submissions made by the pharmacists to that effect. She found
that insofar as payment under the General Medical Scheme was concerned, the two components, which are the dispensing fee and
the ingredient cost, fall within clause 12. Insofar as the other schemes (i.e. the Drugs Payment Scheme and the Long Term Illness
Scheme, etc.) are concerned, clause 12 covers the dispensing fee, the ingredient cost and the retail mark-up. I have already held
that the Minister is entitled also to take into account such rebates as the pharmacists can achieve from the wholesaler.
Reading the Contract, it is clear that the Minister is given extensive powers: she can include or remove any drug from the schemes;
she can abolish schemes; and she can alter rates of pay. There is no reason why she could not recast the whole structure of the
existing scheme, provided she gives proper notice, and introduce a better scheme which enables her to deliver on her statutory
obligations as set out in the Health Acts. As Clarke J. said in the IPU case at para. 7.3:-
“I should note, however, that I do not consider that there is any basis upon which individual pharmacists are entitled to
insist that their current contract continue indefinitely.”
In that context, it is difficult to see how the powers given to her in clause 12(1) should be interpreted in a restrictive way. A plain
reading of the language used in the clause does not suggest such a limited interpretation.
In my view, subject to what I will say on the consultation process, the Minister has every right under the Contract to introduce the
changes now proposed in the Regulations, if she wished. In my view, she would not be in breach of the contractual rights of the
plaintiffs had she so done. I see nothing in the judgments of Finlay Geoghegan J. or Clarke J. in Hickey and IPU respectively that
would prevent me from reaching this conclusion.
From this analysis, it seems that much of the arguments advanced by the plaintiffs on the various constitutional issues become
unsustainable. Furthermore, the Regulations made under the 2009 Act, which attempt to achieve the same result, cannot be
criticised, at least on the grounds that they infringe an identified contractual right. No such right exists in this case.
The plaintiffs argue that if the Minister wishes to change the rates she must first consult them under the Contract. The requirement
for consultation, however, does not, in my view, diminish the Minister's power under the Contract. Had she consulted the plaintiffs
under the Contract, she would still be entitled to dismiss the plaintiffs’ submissions and proceed to alter the rates of remuneration. In
this regard her power is unilateral. Given that the Minister did engage in a serious consultation process, albeit under the 2009 Act,
failure to observe the contractual requirement of consultation at most could only lead to an action for breach of warranty and at
most entitle the plaintiff to sue for damages, which, if the Minister could show, because of the recent history in the negotiations
between the parties and their representatives, that a consultation process expressed to be under the Contract would in all probability
not have influenced her decision, might be negligible or nil.
In any event, as I have determined earlier, there was consultation in the present situation and I am of the view that this
consultation, although done to comply with the provisions of the 2009 Act, was also sufficient to satisfy the contractual requirement
contained in clause 12(1). I am not of the opinion that, even under the Contract, the Minister must “label” the process of
consultation which took place under the terms of the 2009 Act as being the process required under clause 12(1) of the Contract. The
fact is that there was a real, substantial consultation process, which was sufficient to meet the substance of the contractual
obligation under clause 12(1) and there cannot have been a breach of the Contract for that reason. The logic of this leads me to
conclude that there has been no breach of the Contract and therefore no interference with property rights under the Constitution,
and the plaintiffs have no specific constitutional complaint here either. As such, there has been no “attack” in terms of Article 40.3.2
of the Constitution.
This conclusion is necessary, as the case before the court is not pleaded in contract, but rather on wider grounds alleging
constitutional interference with property rights and lack of fair procedures.
In his oral submissions, Mr. Hogan suggested that if the State had, prior to the legislation, entered into a contract with a developer to
pay €60m for a new building, it could now, unilaterally, reduce the price to €20m. I acknowledge that this may be an extreme example
advanced to make a point and that it should not be taken literally, as to do so would necessarily involve consideration of other
factors. The relevance of the argument, however, insofar as it concerns this Court, must be assessed in the context of the facts as
they relate to the plaintiffs and, perhaps, to pharmacists generally, insofar as the plaintiffs’ arguments are those which could be
advanced on behalf of the profession generally.
In the plaintiffs’ circumstances the following observations are appropriate. In contrast to the example advanced by Mr. Hogan, the
Regulations introduced do not propose to deprive the pharmacists of any vested property right which has accrued in the sense that
the developer might have had. The Regulations in this case are prospective and purport to change the rates of remuneration for the
future only. Second, the example given is too simplistic if it suggests that s. 9 might allow such a reduction without other factors
coming into play; questions of quantum meruit, or estoppel or compensation, for example, might be relevant. Third, contrary to what
counsel for the plaintiffs argue, the Minister’s choice of proceeding by way of s. 9 represents a more onerous imposition for the
Minister than if she chose to introduce the rate changes under clause 12(1) which the plaintiffs admit she could do. In my view, s. 9
affords more protection to the plaintiffs and imposes more restrictions on the Minister (especially at s. 9(5)) than the option available
to her under clause 12(1). That this is so can be clearly seen from both the Hickey and the IPU cases. Fourth, it is always open to
the Oireachtas to fundamentally alter the underlying statutory regime set out in the Health Acts and, although this could have a
profound effect on the pharmacists, they would have no legal complaint in such circumstances (see the judgment of Costello J. in
Hempenstall v. Minister for the Environment [1994] 2 I.R. 20). Finally, and most significantly, the pharmacists do not have a
contractual/property right which gives them a right to fix or negotiate the rates paid: this is a matter exclusively for the Minister
under clause 12(1) of the Contract. This, of course, means that because of clause 12(1), the plaintiffs cannot challenge the
constitutionality of s. 9 since, whatever the merits of the general argument advanced by counsel for the plaintiffs, it avails them not.
In advancing the “developer’s” argument the plaintiffs are attempting to adopt a ius tertii. They are not making an argument based on
their own facts, but in reality are attempting to make an argument on a hypothetical and ill-defined situation.
(b) Does the Minister’s reduction of the contractually agreed rates of payment in the Regulations amount to an “unjust
attack” on the plaintiffs’ property rights?
Even if the plaintiffs’ had a contractual entitlement to a fixed rate of payment which could not be varied unilaterally (which I have
found they did not enjoy), I am not satisfied that the unilateral variation of the rates of payment under the 2009 Act and the
Regulations would amount to an “unjust” attack on the plaintiffs’ property rights in the circumstances of this case. “Unjust”, in this
sense, refers, to matters such as retrospectivity, lack of fair procedures, unreasonableness and irrationality, discrimination, lack of
proportionality and, in some cases, lack of compensation (see Hogan and Whyte, J.M. Kelly: The Irish Constitution, (4th ed., pp. 1994
– 2004). Suffice to say at this juncture that not only do I consider that there has not been an attack on the plaintiffs’ constitutional
rights, but also I consider that what encroachment the plaintiffs might complain of, could not be considered to be unjust in any
event.
Article 40.3.2 is not absolute in its terms and obliges the State only to protect the citizen’s property rights “as best it may”. In
Moynihan v. Greensmith [1977] I.R. 55 O’Higgins C.J., giving the judgment of the Supreme Court, said in this connection at p. 71:
“It is noted that the guarantee of protection given by Article 40, s. 3, sub-s. 2, of the Constitution is qualified by the
words ‘as best it may’. This implies circumstances in which the State may have to balance its protection of the right as
against other obligations arising from regard for the common good.”
This phrase, and indeed the word “unjust” in “unjust attack”, must be read in the light of the unusual economic crisis that
necessitated the introduction of the 2009 Act. All the evidence before the court was to the effect that the State is facing an
unprecedented economic crisis, whereby the State is forced to introduce drastic economies and cuts across the board. These
economic realities must inform the interpretation of the constitutional phrases in assessing what the State can do and what
distributive measures it must take to ensure not only the stability of the economy, but the stability of the State itself. It is also
relevant to mention in this context that whatever the State’s duty is in relation to property rights under the Constitution, these have
always to be balanced against “other constitutional duties” that the State may have to uphold. (See Henchy J. in Hamilton v.
Hamilton [1982] I.R. 466, 487.)
Given the exceptional threat to the economic well being of the State and to the people, I have no difficulty in accepting that the
2009 Act is exceptional. Clearly it is capable of affecting persons adversely and that was one of the objectives of the legislation. I am
not satisfied, however, that it could properly be described as draconian in the circumstances where it is clearly a measured,
proportionate and carefully drawn piece of legislation with a number of significant safeguards inbuilt. I have already referred to these,
but it may be well in the present context to refer briefly to them again. Regulations may be made under s. 9 only after a process of
consultation (s. 9(4)); s. 9(5) of the Act stipulates a list of matters which have to be considered when Regulations are being made;
the Regulations must be laid before both Houses of the Oireachtas and are subject to annulment by resolution by either House (s.
9(16)); the Minister for Health and Children must annually review the operation, effectiveness and impact of the amounts and rates
fixed by the Regulations and she is obliged to consider the appropriateness of the amounts and rates having regard to any change of
circumstances and, in particular, any alteration of relevant matters (s. 9(13)); similarly the Minister for Finance has an obligation to
annually review the Regulations (s. 13); a health professional is also entitled to terminate his/her contractual obligations by giving 30
days notice (s. 9(8)).
The plaintiffs suggest that these are no more than theoretical safeguards of little or no value. Apart from such a view being
premature in the circumstances and not based on any real evidence, failure to provide for such safeguards in the legislation would
certainly attract strong criticism from the plaintiffs, and perhaps from objective observers. To date, in any event, the requirements in
the safeguards have been fully complied with.
For the above reasons, I reject the plaintiffs’ argument in so far as it suggests that the Minister in reducing the rate of remuneration
in the individual pharmacist’s Contract, under powers conferred on her by the 2009 Act, wrongfully interfered with property rights
protected in the Constitution or that this amounted to an “unjust attack”.
(c) Do the 2009 Act and the Regulations, in so far as they purport to enable the Minister to make swingeing cuts to the
plaintiffs’ contractually agreed rates of payment, amount to an “abrogation” (as opposed to a “regulation”) of the
plaintiffs’ property rights?
The plaintiffs argue, in their submissions, that the 2009 Act is not a “regulation” of property rights within the meaning of Article 43.2.1
of the Constitution in that:-
“Section 9 asserts a legislative power to give one party the right unilaterally to override the contract and to give that
party (and that party alone) the right to determine how much she should pay for the services in question”.
This argument must be considered in conjunction with the earlier discussion on whether there has been an “unjust attack” on the
plaintiffs’ property rights within the meaning of Article 40.3.2 and Article 43 of the Constitution, and my conclusion that the 2009 Act
and the Regulations relating to the pharmacists do not constitute an “unjust attack” in this case.
In the case of the pharmacists, the Regulations made under s. 9 do not override their Contract with the HSE; the Regulations merely
supplement the Contract, and in no way do they detract from the plaintiffs’ existing rights under the Contract.
There are not many authorities in this jurisdiction which address the question of legislative interference with existing contractual
commitments and it may be appropriate to consider these briefly since they were opened to the court. Before doing so, however, a
general comment is warranted. When a person has entered into a contract with the State, different considerations may come into
play relating to the ability of the State to remain faithful to its commitments. It must be recognised that the State has many
obligations, legislative and constitutional, to other interests and to other members of the community, whereby it may have to make
decisions of priority, especially when there are competing demands for limited or diminishing resources. In entering into contracts,
therefore, it may be incumbent on the State itself to insure that it preserves some flexibility in the terms of the contract which
enables it to modify its obligations, especially in ongoing, rather than one off, contracts, should the political and economic situation
change. That is why a provision like clause 12(1) is necessary, and prudent, in the agreement with the pharmacists. Clause 19(4) of
the Contract also provides that: “Nothing in this Agreement shall interfere with the statutory functions prescribed from time to time of
the Minister or the Chief Execute Officer”. This provision in the Contract appears to me to provide the necessary flexibility of which I
speak.
The plaintiffs characterise the s. 9 power as one which, in truth, abrogates, at least in part, pre-existing contractual entitlements,
rather than a power which “regulates” these entitlements as is provided for in Article 43.2.1. I disagree with this characterisation
also. When one considers the extreme financial crisis that prompted this legislation in the first place, and the fact that the only part
of the Contract that is effected is the rates of payments (admittedly a very important provision); the requirement for prior
consultation; the provision for early withdrawal by the pharmacist if he or she wishes; an annual review of the Regulations; the
obligation on the Minister only to make changes to the rates which are “fair and reasonable” given the objectives of the Act; and,
particularly, clause 12(1) of the Contract, it is difficult to conclude that there is a total “abrogation” of any property rights. In my
view, the legislation is more properly described as “regulation” rather than “abrogation”.
The plaintiffs also raise the question whether the alleged intrusion into the property rights of service providers generally is justifiable?
In this connection one recalls the dictum of Murray C.J. in Re. Article 26 and the Health (Amendment) (No. 2) Bill 2004 [2005] 1 I.R.
105, where he stated at p. 206 of the report:-
“Where a statutory measure abrogates a property right, as this Bill does, and the State seeks to justify it by reference to
the interests of the common good or those of general public policy involving matters of finance alone, such a measure, if
capable of justification, could only be justified as an objective imperative for the purpose of avoiding an extreme financial
crisis or a fundamental disequilibrium in public finances.”
Although a strict reading of this dictum does not unequivocally say that such a crisis will justify such abrogation, it could be argued
that it strongly suggests it. In any event, there can be no doubt that there exists at present, in the State, “an extreme financial
crisis or a fundamental disequilibrium in public finances”.
Leaving aside, for the moment, the question of the presumption of constitutionality to which the 2009 Act is entitled, and where the
onus lies if a challenge is made in that regard, the court must avoid the temptation to deal with these issues in the abstract, and
must concentrate instead on the particular circumstances of the plaintiffs here and the special facts of this case.
The single most important fact, that one cannot escape, irrespective as to how one approaches the matter, is that the plaintiffs do
not have a contractual/property right to prevent the Minister from altering the rates of remuneration in the individual contract, as I
have already set out above.
(d) Did the Minister act in breach of the Contract, by not engaging clause 12(1) of the Contract, and instead relying on her
powers under the 2009 Act in making the Regulations to reduce the rates of payment, and does this breach of the Contract
also amount to a “unjust attack” on the plaintiffs’ property rights.
The plaintiffs next make the argument that since the Minister did not invoke clause 12(1) of the Contract, but instead chose to
introduce the changes in rates of payment by means of Regulations made under powers given to her by the 2009 Act, she acted in
breach of the Contract, and this breach of the Contract constitutes an “unjust attack” on the plaintiffs’ property rights. This
argument must be considered, of course, but the above discussion about the plaintiffs’ rights under the Contract indicates, first, the
limits of the plaintiffs’ contractual rights; second, that the Minister would not have been in breach of the Contract if she introduced
the changes made in the Regulations through the clause 12(1) procedure; third, that the consultation process engaged in under the
2009 Act satisfied the consultation requirement of clause 12(1); and fourth, that there was no infringement of the plaintiffs’ property
rights for the reasons already given.
In my view, the strength of the plaintiffs’ arguments does not change when their counsel shifts from arguing in the context of the
2009 Act to arguing in the context of the Contract; to succeed in either context the plaintiff must show that he has a
contract/property right which is under attack. For reasons already given, the plaintiffs have no such contractual/property right which
prevents the Minister from changing unilaterally the rates of payment in the Contract in this case. Having no such contractual
entitlement, it makes no difference whether the so called “attack” by the Minister is made under the powers she has under clause
12(1) of the Contract or under powers conferred by the 2009 Act. In short, using constitutional language, the “attack” cannot be an
“attack” since it does not infringe any contractual /property right of the plaintiffs. That remains true irrespective of the origin of the
so-called “attack”.
Counsel for the plaintiffs accepts the importance of the plaintiffs’ circumstances, and urges the court to note the specific position of
the pharmacists in the wake of the Hickey case. He points out that although the Minister was entitled to change the rates under
clause 12(1) of the Contract, she has chosen to use the powers given to her by s. 9 of the Act instead. It is argued that the Minister
chose to introduce the changes under the powers conferred on her by the 2009 Act, since s. 9 gives the Minister more power than
clause 12 of the Contract. I do not accept this to be the case. In my view, s. 9 is much more rigorous in its requirements than clause
12 in that regard. Section 9 obliges the Minister to fix the rates at a level which she considers “fair and reasonable”. Moreover, she is
obliged to have regard to the existing contractual arrangements; the submissions made to her; the nature of services rendered and
the different classes of health providers; as well as the State’s ability to continue to provide the health services in place; and the
fairness and efficiency of any reductions. I do not consider these conditions to be less demanding than clause 12, as the plaintiffs
suggest. Moreover, changes introduced by Regulations under s. 9 have to be renewed annually and the pharmacist has an option to
withdraw from the existing arrangements by giving 30 days notice as opposed to three months in the Contract. There is a
consultation requirement in both systems.
If the Minister chooses to alter the rates via the powers conferred by the 2009 Act, it does not deprive the plaintiffs of any right in
this case whether it be a contractual or property right. Clause 12(1) of the Contract does not mandate the form the Minister has to
use when approving or directing the changes in the rates. That she chooses to do so by Regulations under the provisions of s. 9 of
the 2009 Act is immaterial as far as the Contract is concerned. When one reads s. 9, and s. 9(1) of the Act in particular, it is clear
that there is nothing in those provisions to prevent the Regulations in question from meeting the requirements of clause 12(1) of the
Contract.
Ius Tertii Arguments
It is also clear that the Regulations also extend to all health professionals, including pharmacists. The plaintiffs cannot avail of a
general argument that may be open to other service providers to the State, namely, that s. 9 is unconstitutional in their particular
circumstances, given the nature of their contractual arrangements with the State. Whether such an argument would succeed or not
would, of course, depend on the facts of such a case, but for me to hold this to be so in the peculiar circumstances of the plaintiffs’
case would be to make a decision on a hypothetical. To do so where legislation is constitutionally challenged would be wholly
inappropriate, particularly having regard to the presumption of constitutionality.
11. The Equal Treatment Argument
On the assumption that the Regulations result in cuts to the pharmacists of at least 24%, whereas the cuts to other health
professionals only average 8%, the plaintiffs argue that a strong case can be made as to the unconstitutionality of the legislation on
grounds of unequal treatment contrary to Article 40.1 of the Constitution, given the “disproportionate and extreme” nature of the
interference with the rights of the plaintiffs, provided there is no objective justification for such a differential treatment of the various
professionals. In their written submissions, the plaintiffs say: “this is a matter on which the plaintiffs will need expert evidence at the
hearing of the action”. At para. 30 of the written submissions, the plaintiffs say:-
“30. It is submitted that as the plaintiffs can establish such a profound disparate treatment of community pharmacies
when compared with other healthcare professionals, then the onus then (sic) shifts to the defendants and the burden of
demonstrating sufficient objective justification to warrant interference of this extreme and disproportionately far reaching
nature in respect of community pharmacists moves to the defendants. It is respectfully submitted that there is no
legitimate legislative purpose for the unfair and markedly different treatment of the plaintiffs and community pharmacists
generally when compared with other public sector employees or other groups in receipt of State payments.”
Insofar as this argument is based on unequal treatment, it would require, as the plaintiffs admit, evidence of disparate treatment. No
such evidence was, however, produced which means that the court is not in a position to make any finding or judgment on that issue.
Furthermore, as the plaintiffs submit, it is only if evidence is brought forward by them, that the onus shifts to the defendants in this
regard. As it stands, therefore, following the plaintiffs’ own argument, the defendants have no obligation to disprove or justify
something which the plaintiffs have not established by evidence.
In support of their argument on the unfairness issue, the plaintiffs cite a dictum of Barrington J. in Brennan v. Attorney General
[1983] I.L.R.M. 449 at p. 480 where he stated:-
“There is a sense in which to legislate is to discriminate. The legislature in its efforts to redress the inequalities of life or
for other legitimate purposes may have to classify the citizens into adults and children, employers and workers, teachers
and pupils and so on. Pringle J. stated in O’Brien v. Manufacturing Engineering Company Limited [1973] I.R. 334 that such
division of the citizens into different classes was envisaged by the second sentence of Article 40.1. He then added:
‘Therefore, it would appear that there is no unfair discrimination provided that every person in the same class
is treated in the same way.’
No doubt this is true, but it might be prudent to express, what is perhaps implied in it, that the classification must be for
a legitimate legislative purpose, that it must be relevant to that purpose, and that each class must be treated fairly.”
These same dicta were repeated by Barrington J. in the Supreme Court judgment in An Blaoscaod Mór Teo. v. Commissioner of Public
Works (No. 3) [2000] 1 I.R. 6 at pp. 18 – 19.
To get the benefit of these dicta, the unfairness of which the plaintiffs complain is an unfairness “when compared with other
healthcare professionals and the public sector generally”. I have, however, as already noted, no comparative evidence of the
circumstances or contracts of other health professionals or of the public sector generally, to make such a determination in this case.
It should also be pointed out, as the defendants did, that the equality protection under the Constitution extends to human persons
only and may not be availed of by companies or other legal entities. (See, for example, the judgment of Kenny J. in Murphy v.
Attorney General [1982] I.R. 241, 283). In the context of the present proceedings, I accept this argument as being valid, no
authority to the contrary having been produced by the plaintiffs.
In relation to the fall back argument the plaintiffs then make that, if they establish discrimination or unequal treatment in the
legislation, the onus shifts to the State to justify this, it seems to me that, in effect, counsel for the plaintiffs wishes to argue that
the normal presumption of constitutionality extended to legislation, does not apply here. I cannot agree with this proposition. The
normal rule is well established that Acts passed by the Oireachtas are entitled to the presumption of constitutionality until the
contrary is proved. There are many authorities to that effect and I will content myself to quoting one dictum from a recent Supreme
Court decision. In J.D. v. Residential Institutions Redress Board [2009] IESC 59, where the issue was whether fixing the upper age
limit at 18 years for claims brought under the Residential Institution Redress Board Act, amounted to discrimination, Murray C.J.,
delivering the judgment of the Supreme Court in upholding the constitutionality of the Act, on the issue of concern, said:-
“Any person wishing to challenge the compatibility of a provision of an Act of the Oireachtas with the Constitution must
overcome and rebut the fundamental principle of the presumption of constitutionality which operates in favour of the
impugned provision. Hanna J. expressed the matter in the following terms in Pigs Marketing Board v. Donnelly (Dublin) Ltd.
[1939] I.R. 413, at p. 417:-
‘When the Court has to consider the constitutionality of a law it must, in the first place, be accepted as an axiom
that a law passed by the Oireachtas, the elected representatives of the people, is presumed to be constitutional
unless and until the contrary is clearly established.’”
Similarly, Keane C.J., in giving the judgment of the Supreme Court in Re Article 26 and the Planning and Development Bill, 1999 [2000]
2 I.R. 321 at p. 357 stated that:-
“the presumption that every Act of the Oireachtas is constitutional until the contrary is clearly established applies with
particular force to legislation dealing with controversial, social and economic matters”.
The presumption of constitutionality “springs from, and is necessitated by, that respect which one great organ of State owes to
another” (per O’Byrne J. in Buckley v. Attorney General [1950] I.R. 67).
It is true that there are some instances where discrimination is such, for example, if it is based on sex, race, language or religious or
political opinions, that the onus of proof may shift and the State may be obliged to justify the legislation in the first instance. This is
not true, however, of other categories of discrimination. This matter was also addressed by Murray C.J. in the J.D. case. The Chief
Justice referred to the judgments of Hamilton C.J. in Re. Article 26 and the Employment Equality Bill, 1996 [1997] 2 I.R. 321, 346 and
the judgment of Barrington J. in Brennan v. Attorney General [1983] I.L.R.M. 449, 480 and said:
“Neither the statement of Hamilton C.J. that such legislation must be ‘capable of justification’ nor that of Barrington J.
that a ‘classification must be for a legitimate legislative purpose’ should be interpreted as imposing a burden of
justification on the Oireachtas, save, it may be, for cases of invidious categories of the sort considered to be
‘presumptively at least, proscribed by Article 40.1 [though] not particularised…’ (see Hamilton C.J. In the matter of the
Employment Equality Bill 1996, cited above at page 347). It was there said that: ‘manifestly, they would extend to
classifications based on sex, race, language, religious or political opinions.’ The respondent accepts that age, as a ground
of alleged discrimination, does not raise the sort of concerns that are posed by these types of discrimination, and that
the State is not required to justify discrimination in this case. It is submitted, however, that the State is required to
identify a possible justification. The Court is satisfied that it is a matter for the respondent to demonstrate a prima facie
basis for the claim that the classification is discriminatory.”
In that case, the Supreme Court held that fixing the upper limit of 18 years of age to determine who should be compensated under
the Act contained no element of discrimination. According to the Court it was neither arbitrary nor irrational.
This case does not concern “invidious” discrimination of the type identified in the judgments referred to by the Chief Justice in J.D.
and, in my view, the onus in this case rests firmly with the plaintiffs to prove the discrimination in this case, to such an extent that it
renders the Act unconstitutional.
The cases cited to me by the plaintiffs in support of their argument, Hamilton v. Hamilton and Condon v. Minister for Labour, do not
really advance their case. Hamilton was concerned with legislation which proposed to interfere with “vested rights” under a contract
and which was to have a retrospective effect, while Condon, in the words of the plaintiffs’ counsel, was “only of superficial similarity”.
In Condon, the banks as employers were prohibited by a Regulation from paying bank officials increases in remuneration to which they
were contractually entitled. McWilliam J. refused to hold that there was an unjust attack on the property rights of the bank officials.
At p. 7 of his judgment, the learned judge said:-
“On the first submission it is argued that the Acts single out these bank officials for special punitive treatment which is
not applied to other classes of workers, such as the large body of farm workers or the workers not belonging to unions
affiliated to Congress, and that this constitutes invidious discrimination within the meaning of this expression as used by
O’Dalaigh C.J., in O’Brien v. Keogh [1972] I.R. 144 at p. 155.”
Having referred to the judgment of Kenny J. in Murphy v. Attorney General, the judge continues:-
“I do not accept this submission. Kenny J. at page 9 of his judgment states, with reference to section 1 of Article 40:-
‘This section is not a guarantee of equality before the law in all matters or in all circumstances. It is a qualified
guarantee to all citizens as human beings that they will be held equal before the law. It therefore relates to those
attributes which make us human; it is concerned with the essentials of human personality.’”
At p. 9 of his judgment McWilliam J. continued:
“The discrimination alleged in this case had no basis in any facet of human personality or any attribute which makes the
bank officials human, or because they chose the profession of banking, but was based on the view, whether correct or
not, that it was necessary for the common good.”
The learned judge then referred to his judgment in Blake v. Attorney General and said at pp. 10 - 12 of the judgment:
“I said in the Blake case
‘As I see it, the provisions of Article 40 that the State shall by its laws protect as best it may from unjust attack
(and this includes unjust attack by the State itself) the property rights of every citizen ought to be read in
conjunctions with the provisions of Article 43 so as to give effect in so far as possible to both provisions. Thus the
injustice of any attack on property rights should be ascertained by reference to the provisions of Article 43 and,
possibly, also by reference to the Preamble, so as to have full regard to the principles of social justice, the
exigencies of the common good, the principle of justice generally and the attainment of true social order.’
In consideration the injustice of an attack on property rights and the infringement of the right to ownership of property I
do not have to decide whether the measures taken were actually effective or were likely to be effective for the common
good. This is a matter for the legislature. I have only to consider whether there were circumstances which made it
reasonable for the legislature to think such measures would be for the common good. It has been clearly established that
there were such circumstances.
It seems to me that the statement of O’Byrne J., in Foley v. Irish Land Commission (1952) I.R. 118 at page 153 approved
by Lavery J. in Attorney General v. Southern Industrial Trust 94 I.L.T.R. 161 is very apposite to the second branch of the
arguments advanced on behalf of the Plaintiffs here. He said
‘The argument put before the Court on behalf of the Appellant, when brought to its logical conclusion, seems to
involve the proposition that any limitation placed by the Oireachtas on private property, which may result in the loss
of that property by the owner, is repugnant to the Constitution and, accordingly, void. If this argument be sound,
the Constitution has certainly placed serious fetters upon the Legislature in dealing with property rights and the
Court is not prepared to accept such a far-reaching proposition.’
In the present case, the Acts were temporary in application; apart from one witness who appears to have lost some
pension rights, I am not satisfied that anyone was permanently deprived of pecuniary advantage; having regard to the
circumstances of the country at the time, I do not consider that the bank officials were arbitrarily selected; and the same
circumstances made it reasonable for the government to consider that the Acts would operate for the common good.
I am of opinion therefore that these statutes did not infringe the provisions of the Constitution.”
I accept this as a proper statement of the law and an illuminating application to the circumstances of the case.
The plaintiffs urge me to form a conclusion from the mere fact, acknowledged by the defendants, that the cuts introduced in the
Regulations affect pharmacists’ income by at least 24%, whereas all other health professionals (and many other professionals also)
have had their incomes cut only by approximately 8%. This in itself, according to the plaintiffs speaks of arbitrary discrimination and
unequal treatment, as if some kind of res ipsa loquitur applied. I cannot agree. I know nothing of these other health professionals’
contracts on which they provide their services or the objects the State has when engaging their services. To form a conclusion of
arbitrary unequal or disproportionate treatment by contrasting the figures of 24% and 8% alone, would be unwarranted and hasty.
Mr. Hogan then tires to distinguish Condon from the present case by saying that the regulations in Condon were of a temporary
nature only. When, however, we examine the 2009 Act and the Regulations, we note the obligation on the Minister to review the
Regulations annually; that the provisions are not retrospective; and before changes are made, the Minister must consult in a manner
she considers appropriate. Furthermore, the rates fixed by the Regulations must be “fair and reasonable” in the light of the purposes
of the Act and the Minister must have regard to a list of factors including existing contractual relations. Moreover, any health
professional who does not wish to continue to provide the services to the health board may withdraw after 30 days notice.
From the above, I have come to the conclusion that insofar as the plaintiffs wish to challenge the constitutionality of s. 9 of the 2009
Act, the onus lies fairly and squarely on the plaintiffs. In this regard, no comparative evidence has been led by the plaintiffs which
would suggest that the pharmacists have been treated differently from other health professionals, of whose economic situation I am
not aware, or, if such discrimination or unequal treatment exists, whether it is justifiable. In short, I am in no position to conclude
that equals are being treated differently or that unequals are being treated similarly. For this reason, I reject the plaintiffs’ argument
on that ground.
12. Arguments based on Alleged Arbitrariness and Disproportionality
Having found that the Regulations were not ultra vires the Minister under the 2009 Act, are they an unreasonable, disproportionate or
arbitrary interference with the plaintiffs’ rights in themselves? Whatever else may be said about the reductions in the scheme of
payments, it cannot be said that they are arbitrary. It is not for the court to go further than to conclude that they are not obviously
unreasonable in the full context of the market. Furthermore, the reductions can hardly be said to be surprising as they are exactly the
same proposals which were at issue in Hickey, which proposals emerged after a great deal of study involving several reports and
consultation with the various interested parties. These proposals were disallowed in Hickey for a technical reason: that the HSE had
attempted to introduce the changes rather than the Minister who was the authorised person in that regard.
On the discriminatory and unequal treatment argument, I have already said that no evidence of the remuneration of other health
professionals has been led at the hearing of this case. Allegations of unequal treatment and/or discriminatory treatment necessarily
involve a comparison between the position of the plaintiffs and the position of other professionals whom the plaintiffs say are afforded
better treatment. In the present case, I presume that the proper comparison should be with other health professionals who the
plaintiffs say have only been subjected to a cut of 8% or thereabouts.
The main evidence, at the hearing, focused almost exclusively on the history and the economics of pricing within the pharmacy
sector. From this evidence, it is clear that the pricing model adopted with the pharmacists, to achieve objectives set out in the
Health Act 1970, as amended, is complex, involving various balances and trade offs. The price is fixed at the manufacturer/importer
level and has a cascading impact down through the distribution chain. A sliding scale for professional fees, acknowledges that the
smaller pharmacies need the greatest protection. The main objective of the pricing system in the State schemes, as Mr. Ridyard
testified on behalf of the defendants, is to ensure that the prices paid to pharmacists represent good value for the State, while
ensuring, at the same time, the continual existence of an adequate network of pharmacists throughout the country to service the
needs of the community. The voluminous documents, the many reports and the extensive communication between the Department,
the HSE and third parties, all clearly show that the model finally decided upon in the Regulations is anything but arbitrary. There is a
clear rationale for all the cuts made. The sliding fee structure, for example, was designed to ensure that the small pharmacies would
feel the cuts least. A reduction in the ingredient price and a reduction of the mark-ups in the non-GMS health schemes were justified
by reference to the emergence of the rebates to the pharmacists from the wholesalers. From this point of view, the changes could
not be designated arbitrary. Moreover, there was evidence from Mr. Desmond of the Department of Health that, when deciding what
cuts to recommend, each of the health professionals involved were assessed separately and on its own merits. He gave evidence that
two of the health professionals, podiatrists and chiropodists did not have their fees cut at all, and he outlined the reasons for that.
Such an approach does not suggest arbitrariness; rather must it be seen as a considered and rational approach.
The evidence is that the Minister in fixing the rates did bear in mind what level of payment would, at the end of the day, ensure an
economic return, which in turn would guarantee the continuation of a network of pharmacies throughout the country, as sufficient to
deliver the medical services required of the Minister under the legislation. If the Minister is paying too little, she will have to adjust the
rates upwards; if she is paying too much, she will adjust the rate downwards to avoid economic waste and to ensure that she is
getting best value.
The same comments apply to the plaintiffs’ complaints about disproportionality. Again, there is no evidence of this claim in this case. I
readily accept that the cuts will clearly affect the income and profitability of pharmacists in general. I also accept that it may impose
a great burden for some pharmacists. But the State’s concern to get value for money cannot be ignored either. The State has an
obligation to achieve its statutory obligations on a best value basis. It is interesting to note that although it is pleaded, and the case
on behalf of the plaintiffs was opened on the basis that the plaintiffs would become insolvent if the Regulations brought into force the
new rates of remuneration, no such accountancy evidence was introduced at the hearing to that effect, even though counsel for the
defendants invited such evidence at the end of the plaintiffs’ case.
When looking at the question of proportionality, it is also necessary to consider the safeguards in s. 9 of the 2009 Act, which I have
already referred to earlier in this judgment.
Significantly, also, the Act provides for a review of the operation, effectiveness and impact of the changed rates introduced by the
Regulations before 30th June, 2010 and every year after that, bearing in mind changing circumstances (Section 9(13)). If, after such
a review, amendments are required, the Minister has power to make such amendments.
In Re Article 26 and Part V of the Planning and Development Bill 1999 [2000] 2 I.R. 321 Keane C.J. giving the judgment of the
Supreme Court in determining whether the statutory provisions constituted an “unjust attack” on property rights, stated at p. 354
that Part V of the Planning and Development Bill 1999, contains provisions which:-
“… are rationally connected to an objective of sufficient importance to warrant interference with a constitutionally
protected right and, given the serious social problems which they are designed to meet, they undoubtedly relate to
concerns which, in a free and democratic society, should be regarded as pressing and substantial. At the same time, the
court is satisfied that they impair those rights as little as possible and their effects on those rights are proportionate to
the objectives sought to be attained.”
In that case it was held that the Bill which proposed that landowners wishing to develop land were obliged to cede 20% of the land
(or the equivalent value thereof) to the local authority did not constitute a disproportionate interference with the land owner’s
property rights.
A formulation of the principle of proportionality which is favoured in EU law states:-
“…the principle of proportionality, which is one of the general principles of community law, requires that measures adopted
by community institutions do not exceed the limits of what is appropriate and necessary in order to attain the objectives
legitimately pursued by the legislation in question; when there is a choice between several appropriate measures recourse
must be had to the least onerous, and the disadvantages caused must not be disproportionate to the aims pursued…” (C
– 157/96 R. v. Minister for Agriculture, Fisheries and Food ex parte National Farmers’ Union [1998] ECR I–2211, para. 60)
As to the size of the cuts made to the rates of remuneration for pharmacists under the regulations, it is not appropriate for the court
to assess their appropriateness. That is not the court’s function. Suffice to say, as I have already done, that the determination of
the level of the cuts was arrived at after serious, detailed and prolonged study of the pharmacy sector and after many studies and
various calculations were considered in great detail. Bearing in mind, the relevant criteria to be considered as expressed by the
Supreme Court, and to some extent by the ECJ, I have come to the conclusion that the regulations do not represent a
disproportionate response in all the circumstances.
It seems to me that given the emergency nature of the legislation, the above provisions do provide a measure of balance and
proportionality when Regulations are deemed necessary under the Act.
13. European Convention on Human Rights
Although pleaded, very little argument was advanced at the hearing specifically referring to the European Convention on Human
Rights, presumably on the assumption that the provisions of the Constitution provided similar or better protection to the plaintiffs. In
these circumstances, I do not need to address the Convention in any detail given the plaintiffs emphasis in argument.
14. Conclusion
The plaintiffs sought an injunction, various declarations and damages. For the above reasons I refuse the reliefs sought by the
plaintiffs in this case.